Anticoagulation service

The rapid rise in demand for anticoagulation (INR) monitoring is placing both primary and secondary care clinics under increasing pressure. The number of patients receiving oral anticoagulation therapy is growing by about 10% each year making it essential to find more capacity to ensure these patients receive the best level of care.

Managing this additional demand will place a massive strain upon both GP and hospital-based clinics. Devolution of INR clinics to community pharmacy is a practical solution and one which releases valuable resources, allowing GP surgeries and primary care organisations to focus their attention on other areas of patient care.

Lloydspharmacy has developed a complete INR monitoring and dosage service which has been approved by Anticoagulation Europe. Lloydspharmacy can work with primary care organisations to tailor this service to meet local needs.

Blood Pressure Measurement

16million people in the UK have high blood pressure. This service aims to increase awareness of hypertension and its associated risks, encourage positive lifestyle adjustment and to empower those with hypertension to have greater control over and to improve their health.

Cardiovascular Disease Risk Assessment and Lipid Moinitoring

Cardiovascular disease (CVD) remains one of the leading killers in the UK. This service includes both a targeted screening service for those at risk of developing CVD and a monitoring service for those already prescribed certain lipid-lowering medicines. Appropriate lifestyle advice is offered and referral to the doctor when necessary. This service is currently being commissioned by a number of primary care organisations.


Home \| Services We Offer \| About Us \| Talk To Us
Anticoagulation, Blood Pressure and Cardiovascular Disease Risk Asthma and Chronic Obstructive Pulmonary Disease (COPD) Diabetes Stop Smoking Substance Misuse Personal Health	Anticoagulation service The rapid rise in demand for anticoagulation (INR) monitoring is placing both primary and secondary care clinics under increasing pressure. The number of patients receiving oral anticoagulation therapy is growing by about 10% each year making it essential to find more capacity to ensure these patients receive the best level of care. Managing this additional demand will place a massive strain upon both GP and hospital-based clinics. Devolution of INR clinics to community pharmacy is a practical solution and one which releases valuable resources, allowing GP surgeries and primary care organisations to focus their attention on other areas of patient care. Lloydspharmacy has developed a complete INR monitoring and dosage service which has been approved by Anticoagulation Europe. Lloydspharmacy can work with primary care organisations to tailor this service to meet local needs. Blood Pressure Measurement 16million people in the UK have high blood pressure. This service aims to increase awareness of hypertension and its associated risks, encourage positive lifestyle adjustment and to empower those with hypertension to have greater control over and to improve their health. Cardiovascular Disease Risk Assessment and Lipid Moinitoring Cardiovascular disease (CVD) remains one of the leading killers in the UK. This service includes both a targeted screening service for those at risk of developing CVD and a monitoring service for those already prescribed certain lipid-lowering medicines. Appropriate lifestyle advice is offered and referral to the doctor when necessary. This service is currently being commissioned by a number of primary care organisations.

In Partnership with EPG Online